{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:51:23Z","timestamp":1761511883113},"publisher-location":"Chichester, UK","reference-count":143,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003868","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T22:14:00Z","timestamp":1069452840000},"source":"Crossref","is-referenced-by-count":17,"title":["Oral morphine for cancer pain"],"prefix":"10.1002","author":[{"given":"PJ","family":"Wiffen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JE","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Barden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HJM","family":"McQuay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,20]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD003868-BIB1|cit1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0885-3924(97)00082-1","article-title":"Transdermal fentanyl versus sustained-release oral morphine in cancer","volume":"13","author":"Ahmedzai","year":"1997","journal-title":"Journal of Pain and Symptom Management"},{"issue":"6","key":"10.1002\/14651858.CD003868-BIB2|cit2","first-page":"653","article-title":"Control of severe pain with sustained-release morphine tablets versus oral morphine solution","volume":"140","author":"Arkinstall","year":"1989","journal-title":"Canadian Medical Association Journal"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD003868-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/1097-0142(19890601)63:11<2294::AID-CNCR2820631139>3.0.CO;2-X","article-title":"Analgesic response to single and multiple doses of controlled release morphine tablets and morphine oral solution in cancer patients","volume":"63","author":"Goughnour","year":"1989","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB4|cit4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/j.1552-4604.1998.tb04380.x","article-title":"Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain","volume":"38","author":"Babul","year":"1998","journal-title":"Journal of Clinical Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD003868-BIB5|cit5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0885-3924(92)90018-D","article-title":"A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer pain","volume":"7","author":"Boureau","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB6|cit6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(97)00012-2","article-title":"Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain","volume":"14","author":"Broomhead","year":"1997","journal-title":"Journal of Pain and Symptom Management"},{"issue":"10","key":"10.1002\/14651858.CD003868-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1200\/JCO.1998.16.10.3222","article-title":"Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain","volume":"16","author":"Bruera","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD003868-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/1097-0142(19890601)63:11<2355::AID-CNCR2820631147>3.0.CO;2-#","article-title":"Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design","volume":"63","author":"Cundiff","year":"1989","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB9|cit9","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/0885-3924(88)90082-6","article-title":"Evaluation of a controlled- and immediate release morphine and a unique well-controlled study design in cancer pain","volume":"3","author":"Cundiff","year":"1988","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1200\/JCO.1995.13.4.1004","article-title":"Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain","volume":"13","author":"Conno","year":"1995","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD003868-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/0959-8049(94)90166-X","article-title":"Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphine","volume":"30A","author":"Dellemijn","year":"1994","journal-title":"European Journal of Cancer"},{"issue":"7","key":"10.1002\/14651858.CD003868-BIB12|cit12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0885-3924(92)90017-C","article-title":"The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine","volume":"7","author":"Deschamps","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB13|cit13","first-page":"521","article-title":"Effects of controlled released morphine on quality of life for cancer pain","volume":"16","author":"Ferrell","year":"1989","journal-title":"Oncology Nursing Forum"},{"issue":"5","key":"10.1002\/14651858.CD003868-BIB14|cit14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1200\/JCO.1993.11.5.967","article-title":"Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer","volume":"11","author":"Finn","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB15|cit15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00044011-199714030-00004","article-title":"Comparison of two oral morphine formulations for chronic severe pain of malignant and non malignant origin Kapanol (R) vs MST (R)","volume":"14","author":"Fl\u00f6ter","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003868-BIB16|cit16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00044011-199700141-00006","article-title":"Double-blind crossover clinical and pharmacokinetic comparison of oral morphine syrup and sustained release morphine sulfate capsules in patients with cancer-related pain","volume":"14","author":"Gillette","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB17|cit17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0304-3959(96)03269-1","article-title":"Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain","volume":"69","author":"Gourlay","year":"1997","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB18|cit18","first-page":"34","article-title":"Clinical Evaluation of the analgesic effect of sustained release morphine sulfate microgranules in patients with terminal cancer","volume":"14 Suppl","author":"Guo-Zhu","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"8","key":"10.1002\/14651858.CD003868-BIB19|cit19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2044.1987.tb04107.x","article-title":"Controlled release morphine tablets: a double blind trial in patients with advanced cancer","volume":"42","author":"Hanks","year":"1987","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB20|cit20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0885-3924(94)00067-U","article-title":"Efficacy and pharmacokinetics of a new controlled-release morphine sulfate 200-mg tablet","volume":"10","author":"Hanks","year":"1995","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB21|cit21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3959(97)00072-9","article-title":"Controlled-release oxycodone and morphine in cancer related pain","volume":"73","author":"Heiskanen","year":"1997","journal-title":"Pain"},{"issue":"11","key":"10.1002\/14651858.CD003868-BIB22|cit22","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-2044.1989.tb09143.x","article-title":"Controlled release morphine in cancer pain. Is a loading dose required when the formulation is changed?","volume":"44","author":"Hoskin","year":"1989","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1002\/14651858.CD003868-BIB23|cit23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/clpt.1990.85","article-title":"Morphine and oxycodone hydrochloride in the management of cancer pain","volume":"47","author":"Kalso","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/14651858.CD003868-BIB25|cit24","series-title":"Advances in cancer pain mangement. The International Symposium on pain Control. Toronto: Purdue Frederick Inc","article-title":"Controlled evaluation and ongoing experience with sustained release morphine in patients with advanced cancer pain","author":"Henriksen","year":"1986"},{"issue":"9","key":"10.1002\/14651858.CD003868-BIB24|cit25","first-page":"780","article-title":"Slow-release morphine tablets compared with conventional morphine tablets in the treatment of cancer pain Morfin-depottabletter og konventionelle morfintabletter ved cancersmerter","volume":"147","author":"Knudsen","year":"1985","journal-title":"Ugeskr Laeger"},{"key":"10.1002\/14651858.CD003868-BIB26|cit26","first-page":"73","article-title":"Modern aspects of Morphine therapy","volume-title":"Advances in Morphine therapy. The 1983 International Symposium on Pain Control. Royal Society of Medicine International Congress and Symposium Series no 64","author":"Kossman","year":"1983"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB27|cit27","first-page":"257","article-title":"Analgesic efficacy and side effects of oral tramadol and morphine administered orally in the treatment of cancer pain","volume":"51","author":"Leppart","year":"2001","journal-title":"Nowotwory"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB28|cit28","first-page":"435","article-title":"The Brompton mixture versus morphine solution given orally: effects on pain","volume":"120","author":"Melzack","year":"1979","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB29|cit29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0885-3924(98)80004-3","article-title":"Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain","volume":"15","author":"Mercadante","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"issue":"6","key":"10.1002\/14651858.CD003868-BIB30|cit30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0885-3924(95)00063-5","article-title":"Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration","volume":"10","author":"Mignault","year":"1995","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868-BIB31|cit31","first-page":"1","article-title":"A randomised crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain","volume":"2","author":"Moriarty","year":"1999","journal-title":"Journal of Clinical Research"},{"key":"10.1002\/14651858.CD003868-BIB32|cit32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1090-3801(98)90020-9","article-title":"Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: A randomized, double-blind, parallel-group study","volume":"2","author":"Mucci LoRusso","year":"1998","journal-title":"European Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868-BIB33|cit33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/026921639701100608","article-title":"A randomized crossover study comparing the efficacy and tolerability of a novel once-daily morphine preparation (MXL capsules) with MST Continus tablets in cancer patients with severe pain","volume":"11","author":"O'Brien","year":"1997","journal-title":"Palliative Medicine"},{"issue":"12","key":"10.1002\/14651858.CD003868-BIB34|cit34","first-page":"672","article-title":"Comparison of morphine slow release tablet (MST) and morphine sulphate solution (MSS) in the treatment of cancer pain","volume":"76","author":"Panich","year":"1993","journal-title":"Journal of Medical Association of Thailand"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD003868-BIB35|cit35","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/1097-0142(19890601)63:11<2284::AID-CNCR2820631137>3.0.CO;2-3","article-title":"Oral controlled release morphine sulfate. Analgesic efficacy and side effects of a 100 mg tablet in cancer pain patients","volume":"63","author":"Portenoy","year":"1989","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB36|cit36","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/0885-3924(88)90076-0","article-title":"Controlled-release morphine sulfate: analgesic efficacy and side effects of a 100 mg tablet","volume":"3","author":"Portenoy","year":"1988","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD003868-BIB37|cit37","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0959-8049(94)90524-X","article-title":"Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain","volume":"30A","author":"Rodriguez","year":"1994","journal-title":"European Journal of Cancer"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003868-BIB38|cit38","first-page":"S55","article-title":"Morphine at gramme doses: kinetics, dynamics and clinical need","volume":"67","author":"Smith","year":"1991","journal-title":"Postgraduate Medical Journal"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD003868-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/1097-0142(19890601)63:11<2275::AID-CNCR2820631136>3.0.CO;2-4","article-title":"Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients","volume":"63","author":"Thirlwell","year":"1989","journal-title":"Cancer"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD003868-BIB41|cit40","first-page":"58","article-title":"The measurement of pain in terminal carcinoma","volume":"4","author":"Twycross","year":"1976","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD003868-BIB40|cit41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0304-3959(77)90072-0","article-title":"Choice of strong analgesic in terminal cancer: diamorphine or morphine?","volume":"3","author":"Twycross","year":"1977","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB42|cit42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1399-6576.1988.tb02711.x","article-title":"Opioid treatment for radiating cancer pain: oral administration vs. epidural techniques","volume":"32","author":"Vainio","year":"1988","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB43|cit43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0885-3924(86)80042-2","article-title":"A randomized study on oral administration of morphine and methadone in the treatment of cancer pain","volume":"1","author":"Ventafridda","year":"1986","journal-title":"Journal of Pain and Symptom Management"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB44|cit44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0885-3924(89)90005-5","article-title":"Clinical observations on controlled release morphine in cancer pain","volume":"4","author":"Ventafridda","year":"1989","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB45|cit45","first-page":"137","article-title":"Sustained release morphine in cancer pain","volume":"9","author":"Vielvoye-Kerkmeer","year":"2002","journal-title":"European Journal of Palliative Care"},{"key":"10.1002\/14651858.CD003868-BIB47|cit46","first-page":"99","article-title":"A controlled study of MST Continus tablets for chronic pain in advanced cancer","volume-title":"Advances in morphine therapy: International symposium on pain control","author":"Walsh","year":"1984"},{"key":"10.1002\/14651858.CD003868-BIB46|cit47","first-page":"727","article-title":"Clinical evaluation of slow release morphine tablets","volume":"9","author":"Walsh","year":"1985","journal-title":"Advances in Pain Research and Therapy"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB48|cit48","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00000421-199206000-00018","article-title":"A controlled study of sustained-release morphine sulfate tablets in chronic pain from advanced cancer","volume":"15","author":"Walsh","year":"1992","journal-title":"American Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB49|cit49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/oxfordjournals.annonc.a058765","article-title":"Oral tramadol, a mu-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain","volume":"5","author":"Wilder-Smith","year":"1994","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB50|cit50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00685556","article-title":"Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients","volume":"31","author":"Wilkinson","year":"1992","journal-title":"Cancer Chemotherapy and Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB51|cit51","first-page":"25","article-title":"Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain","volume":"35","author":"Wong","year":"1997","journal-title":"Acta Anaesthesiologica Sinica"},{"issue":"7","key":"10.1002\/14651858.CD003868-BIB52|cit52","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0885-3924(92)90019-E","article-title":"Pharmacokinetics of two novel rectal controlled-release morphine formulations","volume":"7","author":"Babul","year":"1992","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB53|cit53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/009127007701700402","article-title":"Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer","volume":"17","author":"Beaver","year":"1977","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB54|cit54","first-page":"92","article-title":"Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone","volume":"207","author":"Beaver","year":"1978","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB55|cit55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00002508-199412000-00012","article-title":"Comparison of morphine and ketorolac for intravenous patient-controlled analgesia in postoperative cancer patients","volume":"10","author":"Bosek","year":"1994","journal-title":"Clinical Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB56|cit56","first-page":"275","article-title":"Principles of cancer pain management. Use of long-acting oral morphine","volume":"28","author":"Brooks","year":"1989","journal-title":"Journal of Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB57|cit57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00044011-199714020-00008","article-title":"Comparative bioavailability of sustained-release morphine sulfate capsules versus pellets","volume":"14","author":"Broomhead","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD003868-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1200\/JCO.1995.13.6.1520","article-title":"Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation","volume":"13","author":"Bruera","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003868-BIB59|cit59","first-page":"132","article-title":"A comparison of morphine sulphate solution and MST Continus tablets in the treatment of pain in terminally ill at home","volume-title":"International Symposium on Pain Control. Royal Society of Medicines Services International Congress and Syposium Series 123","author":"Buxton","year":"1987"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB60|cit60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/j.1875-9114.1990.tb02577.x","article-title":"A multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac tromethamine, acetaminophen plus codeine, and placebo in cancer pain","volume":"10","author":"Carlson","year":"1990","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003868-BIB61|cit61","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.44.5.857","article-title":"Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies","volume":"44","author":"Cherny","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003868-BIB62|cit62","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1213\/00000539-198702001-00029","article-title":"Morphine inhalation versus intravenous infusion in pain treatment after abdominal surgery","volume":"66","author":"Chrubasik","year":"1987","journal-title":"Anesthesia and Analgesia"},{"issue":"5","key":"10.1002\/14651858.CD003868-BIB63|cit63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/07357909209024792","article-title":"Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use","volume":"10","author":"Citron","year":"1992","journal-title":"Cancer Investigation"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB64|cit64","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0893-133X(95)00205-R","article-title":"Effects of oral morphine on cold pressor tolerance time and neuropsychological performance","volume":"15","author":"Cleeland","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB65|cit65","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0360-3016(97)00076-X","article-title":"Low energy Helium-Neon laser in the prevention of oral mucositis in","volume":"38","author":"Cowen","year":"1997","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB66|cit66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1300\/J011v09n01_07","article-title":"Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer","volume":"9","author":"Davis","year":"1993","journal-title":"Hospice Journal"},{"issue":"Sppl. 1","key":"10.1002\/14651858.CD003868-BIB67|cit67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2165\/00044011-199700141-00007","article-title":"Randomised crossover comparison of the pharmacokinetic profiles of two sustained release morphine sulfate formulations in patients with cancer-related pain","volume":"14","author":"Bernardi","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB68|cit68","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0885-3924(97)00361-8","article-title":"Long-term treatment of cancer pain with transdermal fentanyl","volume":"15","author":"Donner","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB69|cit69","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3959(89)90020-1","article-title":"Treatment of severe cancer pain by low-dose continuous subcutaneous morphine","volume":"36","author":"Drexel","year":"1989","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB70|cit70","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00007691-199904000-00011","article-title":"The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories","volume":"21","author":"Du","year":"1999","journal-title":"Therapeutic Drug Monitoring"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB71|cit71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0885-3924(92)90101-M","article-title":"A double-blind, crossover trial of intravenous clodronate in metastatic bone pain","volume":"7","author":"Ernst","year":"1992","journal-title":"Journal of Pain & Symptom Management"},{"issue":"8","key":"10.1002\/14651858.CD003868-BIB72|cit72","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jnci\/90.8.611","article-title":"Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients","volume":"90","author":"Farrar","year":"1998","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB73|cit73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0885-3924(95)00148-4","article-title":"Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain","volume":"11","author":"Faura","year":"1996","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB74|cit74","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/026921639300700407","article-title":"A novel morphine sulphate preparation: clinical trial of a controlled-release morphine suspension in cancer pain","volume":"7","author":"Forman","year":"1993","journal-title":"Palliative Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003868-BIB75|cit75","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/000348940010900711","article-title":"Cervical versus thoracic epidural morphine for the treatment of head and neck cancer pain","volume":"109","author":"Georgiou","year":"2000","journal-title":"Annals of Otology, Rhinology & Laryngology"},{"issue":"5","key":"10.1002\/14651858.CD003868-BIB76|cit76","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1200\/JCO.1993.11.5.973","article-title":"Dose-ranging study of oxycodone for chronic pain in advanced cancer","volume":"11","author":"Glare","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB77|cit77","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0304-3959(86)90234-4","article-title":"A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer","volume":"25","author":"Gourlay","year":"1986","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB78|cit78","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0304-3959(94)00204-R","article-title":"Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution","volume":"61","author":"Gourlay","year":"1995","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868-BIB79|cit79","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/026921639000400307","article-title":"Evaluation of the palatability of Oramorph - a proprietary preparation of oral morphine sulphate","volume":"4","author":"Griffith","year":"1990","journal-title":"Palliative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB80|cit80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/j.1552-4604.1995.tb04743.x","article-title":"Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone","volume":"35","author":"Hagen","year":"1995","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003868-BIB81|cit81","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1016\/0304-3959(84)90730-9","article-title":"Controlled release morphine tablets in chronic cancer pain","volume":"Suppl","author":"Hanks","year":"1984","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/026921638700100102","article-title":"Opioid analgesics in the management of pain in patients with cancer - a review","volume":"1","author":"Hanks","year":"1987","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD003868-BIB83|cit83","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/1097-0142(19890601)63:11<2378::AID-CNCR2820631150>3.0.CO;2-8","article-title":"Controlled release Morphine (MST Contin) in advanced cancer","volume":"63","author":"Hanks","year":"1989","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD003868-BIB84|cit84","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00279975","article-title":"Single dose and steady state kinetics of morphine and its metabolites in cancer patients - a comparison of two oral formulations","volume":"40","author":"Hasselstrom","year":"1991","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB85|cit85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3959(90)90062-I","article-title":"Self-administration of morphine in bone marrow transplant patients reduces drug requirement","volume":"40","author":"Hill","year":"1990","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB86|cit86","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0304-3959(92)90235-4","article-title":"Patient-controlled analgesic infusions: alfentanil versus morphine","volume":"49","author":"Hill","year":"1992","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868-BIB87|cit87","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/07357909709047595","article-title":"A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain","volume":"15","author":"Hoffman","year":"1997","journal-title":"Cancer Investigation"},{"key":"10.1002\/14651858.CD003868-BIB88|cit88","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/0304-3959(81)90506-6","article-title":"Analgesic assay of oral zomepirac and intramuscular morphine in advanced cancer patients","volume":"Suppl","author":"Houde","year":"1981","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868-BIB89|cit89","first-page":"254","article-title":"Relative analgesic potency of intramuscular heroin and morphine in cancer patients with postoperative pain: a preliminary report","volume":"27","author":"Kaiko","year":"1979","journal-title":"NIDA Res Monogr"},{"key":"10.1002\/14651858.CD003868-BIB90|cit90","first-page":"205","article-title":"Oral fenoprofen compared to intramuscular morphine and oral aspirin in cancer patients with postoperative pain","volume":"49","author":"Kaiko","year":"1984","journal-title":"National Institute on Drug Abuse Research Monographs"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB91|cit91","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0304-3959(87)90004-2","article-title":"Cocaine and morphine interaction in acute and chronic cancer pain","volume":"31","author":"Kaiko","year":"1987","journal-title":"Pain"},{"issue":"11 Suppl","key":"10.1002\/14651858.CD003868-BIB92|cit92","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1002\/1097-0142(19890601)63:11<2348::AID-CNCR2820631146>3.0.CO;2-V","article-title":"The United States experience with oral controlled release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15 mg, 30 mg, 60 mg, and 100 mg tablet strengths in normal subjects","volume":"63","author":"Kaiko","year":"1989","journal-title":"Cancer"},{"issue":"2-3","key":"10.1002\/14651858.CD003868-BIB93|cit93","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0304-3959(96)03161-2","article-title":"Epidural and subcutaneous morphine in the management of cancer pain: A double-blind cross-over study","volume":"67","author":"Kalso","year":"1996","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD003868-BIB94|cit94","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.1987.5.6.956","article-title":"Controlled release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation","volume":"5","author":"Khojasteh","year":"1987","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB95|cit95","first-page":"259","article-title":"Preemptive analgesia on postmastectomy pain syndrome with ibuprofen-arginine","volume":"84","author":"Lakdja","year":"1997","journal-title":"Bulletin Du Cancer"},{"issue":"6","key":"10.1002\/14651858.CD003868-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/00000542-199906000-00005","article-title":"Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management","volume":"90","author":"Lauretti","year":"1999","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0742-969X.1990.11882680","article-title":"A multi investigator clinical evaluation of oral controlled release morphine (MS Contin tablets) administered to cancer patients","volume":"6","author":"Lazarus","year":"1990","journal-title":"Hospice Journal"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB98|cit98","first-page":"289","article-title":"Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer","volume":"107","author":"Li","year":"1994","journal-title":"Chinese Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB99|cit99","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/cs0880447","article-title":"Effects of inhaled nebulized morphine on ventilation and breathlessness during exercise in healthy man","volume":"88","author":"Masood","year":"1995","journal-title":"Clinical Science"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB100|cit100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2125.1996.tb00192.x","article-title":"Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects","volume":"41","author":"Masood-AR","year":"1996","journal-title":"British Journal of Clininical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB101|cit101","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/j.1552-4604.1987.tb02177.x","article-title":"Management of cancer pain with oral controlled-release morphine sulfate","volume":"27","author":"Meed","year":"1987","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB102|cit102","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3959(89)90021-3","article-title":"Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer pain","volume":"36","author":"Minotti","year":"1989","journal-title":"Pain"},{"issue":"2-3","key":"10.1002\/14651858.CD003868-BIB103|cit103","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3959(97)00157-7","article-title":"Double-blind evaluation of short-term analgesic efficacy of orally administered diclofenac, diclofenac plus codeine, and diclofenac plus imipramine in chronic cancer pain","volume":"74","author":"Minotti","year":"1998","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD003868-BIB104|cit104","first-page":"576","article-title":"Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo","volume":"30","author":"Morgan","year":"1992","journal-title":"International Journal of Clinical Pharmacology,Therapy and Toxicology"},{"issue":"8995","key":"10.1002\/14651858.CD003868-BIB105|cit105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(96)90339-6","article-title":"Randomised trial of oral morphine for chronic non-cancer pain","volume":"347","author":"Moulin","year":"1996","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB106|cit106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3959(92)90182-B","article-title":"Octreotide: a potent new non-opiate analgesic for intrathecal infusion","volume":"49","author":"Penn","year":"1992","journal-title":"Pain"},{"issue":"2-3","key":"10.1002\/14651858.CD003868-BIB107|cit107","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0304-3959(98)00179-1","article-title":"Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study","volume":"79","author":"Portenoy","year":"1999","journal-title":"Pain"},{"issue":"10","key":"10.1002\/14651858.CD003868-BIB108|cit108","first-page":"91","article-title":"Tramadol and the possibilities for its use with cancer patients","volume":"64","author":"Repas","year":"1992","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD003868-BIB109|cit109","first-page":"397","article-title":"Rectal versus oral Morphine for the management of cancer pain. A double-blind, double dummy cross-over trial","volume-title":"Proceedings of the Annual Meeting of the American Society of Clinical Oncology","author":"Ripamonti","year":"1992"},{"key":"10.1002\/14651858.CD003868-BIB110|cit110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(96)03186-7","article-title":"Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treament","volume":"68","author":"Roca","year":"1996","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD003868-BIB111|cit111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3959(98)00019-0","article-title":"Nimodipine-enhanced opiate analgesia in cancer patients requiring","volume":"76","author":"Santillan","year":"1998","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB112|cit112","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/clpt.1988.46","article-title":"Rescue factor: A design for evaluating long-acting analgesics","volume":"43","author":"Savarese","year":"1988","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD003868-BIB113|cit113","first-page":"689","article-title":"Intrathecal morphine for postoperative pain","volume":"41","author":"Schaer","year":"1992","journal-title":"Anaesthesist"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB114|cit114","first-page":"25","article-title":"High-dose epidural opioid treatment of malignant pain","volume":"151","author":"Sjogren","year":"1989","journal-title":"Ugeskrift Laeger"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB115|cit115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0885-3924(98)00044-X","article-title":"A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain","volume":"16","author":"Sloan","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868-BIB116|cit116","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/0304-3959(81)90320-1","article-title":"Comparison of the analgesic effect of parenteral levonantradol to morphine and placebo in patients with moderate to severe pain of cancer","volume":"Suppl","author":"Stambaugh","year":"1981","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868-BIB117|cit117","first-page":"838","article-title":"Comparison of immediate vs. sustained released oral morphine in cancer patients - acute pain novel study design","volume":"30","author":"Stambaugh","year":"1990","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB118|cit118","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/026921639601000208","article-title":"An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer","volume":"10","author":"Sykes","year":"1996","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD003868-BIB119|cit119","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF00609900","article-title":"Steady-state kinetics and analgesic effect of oral morphine in cancer patients","volume":"24","author":"S\u00e4we","year":"1983","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003868-BIB120|cit120","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1016\/0304-3959(90)92870-V","article-title":"Tramadol hydrochloride in the relief of cancer pain. A double blind comparison against sustained release morphine","volume":"Suppl","author":"Tawfik","year":"1990","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB121|cit121","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/j.1552-4604.1980.tb01705.x","article-title":"Relative analgesic potency of oral zomepirac and intramuscular morphine in cancer patients with postoperative pain","volume":"20","author":"Wallenstein","year":"1980","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003868-BIB122|cit122","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/0304-3959(84)90432-9","article-title":"Controlled study of slow release morphine for chronic pain in advanced cancer","volume":"Suppl","author":"Walsh","year":"1984","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868-BIB123|cit123","first-page":"Abs No 1035","article-title":"Controlled study of oral slow release morphine in pain due to advanced cancer","volume-title":"Proceedings of the Annual Meeting of the American Society of Clinical Onclogy","volume":"9","author":"Walsh","year":"1985"},{"issue":"1","key":"10.1002\/14651858.CD003868-BIB124|cit124","first-page":"53","article-title":"Analgesia with oral narcotics and added ibuprofen in cancer patients","volume":"4","author":"Weingart","year":"1985","journal-title":"Clinical Pharmacy"},{"issue":"5","key":"10.1002\/14651858.CD003868-BIB125|cit125","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00007691-199310000-00003","article-title":"Morphine pharmacokinetics and effects on salivation and continuous reaction times in healthy volunteers","volume":"15","author":"Westerling","year":"1993","journal-title":"Therapeutic Drug Monitoring"},{"issue":"11","key":"10.1002\/14651858.CD003868-BIB126|cit126","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1177\/106002809202601113","article-title":"Transdermal fentanyl","volume":"26","author":"Yee","year":"1992","journal-title":"Annals of Pharmacotherapy"},{"issue":"(1-2)","key":"10.1002\/14651858.CD003868-BIB127|cit127","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3959(02)00328-7","article-title":"Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial","volume":"101","author":"Klepstad","year":"2003","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD003868-BIB128|cit128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpainsymman.2003.10.006","article-title":"Use of strong opioids in advanced cancer pain: a randomized trial","volume":"27","author":"Marinangeli","year":"2004","journal-title":"Journal of Pain & Symptom Management"},{"key":"10.1002\/14651858.CD003868-BIB129|cit129","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0885-3924(98)00094-3","article-title":"Peak plasma concentrations after oral morphine - a systematic review","volume":"16","author":"Collins","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003868-BIB130|cit130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003868-BIB131|cit131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3959(97)00142-5","article-title":"Systematic review of factors affecting the ratios of morphine and its major metabolites","volume":"74","author":"Faura","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868-BIB132|cit132","unstructured":"Goudas L Carr DB Bloch R Management of cancer pain Evidence report\/Technology Assessment No 35 ARHQ Publication No 02-E002. Rockville MD 2001"},{"key":"10.1002\/14651858.CD003868-BIB133|cit133","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780192632340.001.0001","volume-title":"Oxford Textbook of Clinical Pharmacology and Drug Therapy","author":"Grahame-Smith","year":"2002"},{"issue":"5","key":"10.1002\/14651858.CD003868-BIB134|cit134","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD003868-BIB135|cit135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0304-3959(96)03033-3","article-title":"Developing a database of published reports of randomised clinical trials in pain research","volume":"66","author":"Jadad","year":"1996","journal-title":"Pain"},{"key":"10.1002\/14651858.CD003868-BIB136|cit136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD003868-BIB137|cit137","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"volume-title":"Martindale. The complete drug reference","year":"1999","author":"Parfitt","key":"10.1002\/14651858.CD003868-BIB138|cit138"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB139|cit139","article-title":"Hydromorphone for acute and chronic pain (Cochrane Review)","author":"Quigley","year":"2002","journal-title":"The Cochrane Library"},{"issue":"4","key":"10.1002\/14651858.CD003868-BIB140|cit140","article-title":"Oxycodone for cancer-related pain (Protocol for a Cochrane Review)","author":"Reid","year":"2002","journal-title":"The Cochrane Library"},{"volume-title":"History of Pain","year":"1993","author":"Rey","key":"10.1002\/14651858.CD003868-BIB141|cit141"},{"issue":"2","key":"10.1002\/14651858.CD003868-BIB142|cit142","article-title":"Fentanyl for chronic pain (Protocol for a Cochrane review)","author":"Ribeiro","year":"2003","journal-title":"The Cochrane Library"},{"volume-title":"Cancer Pain Relief","year":"1986","key":"10.1002\/14651858.CD003868-BIB143|cit143"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003868","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T13:49:43Z","timestamp":1704980983000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003868"}},"subtitle":[],"editor":[{"given":"Philip","family":"Wiffen","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2003,10,20]]},"references-count":143,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003868","relation":{},"subject":[],"published":{"date-parts":[[2003,10,20]]}}}